Groowe Groowe / Newsroom / BMY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BMY News

Bristol-Myers Squibb Co.

Harbour BioMed Appoints Dr. Adam Zong as President

prnewswire.com
MRK BMY PFE

Generalized Myasthenia Gravis Market on the Brink of Change: 8 Promising Late-Stage Drugs Signal a New Treatment Era | DelveInsight

globenewswire.com
IMVT ROIV CART NVS MRK REGN UCB JNJ AMGN ARGX KYMR CABA BMY BHVN

Sport Beach is Back for Cannes 2026

accessnewswire.com
ADBE PEP EA TTD Z TROW AMZN DDOG F GOOG INTC META NFLX NVDA SPOT STX TSLA CRM SPGI MSFT GOOGL FDX CMCSA DIS AAPL IBM GE BA GS JPM BAC WMT COST TGT BABA JD PDD ETSY EBAY PYPL COIN HOOD UPST SOFI PLTR SNOW CRWD PANW ZS FTNT DD DOW LMT GD RTX CAT DE AGCO CNH HON MMM XOM CVX SHEL T VZ TMUS LYFT UBER GILD AMGN BMY PFE MRK JNJ ABBV LLY NVS AZN BIIB REGN VRTX MDLZ KHC CL PG BANC

Adimab Collaborator GSK Receives Additional Marketing Approval for Depemokimab

prnewswire.com
GSK BIIB LLY MRK TAK ALNY BMY NVS REGN VRTX

Beeline Medicines Debuts to Deliver Category-Leading Precision Therapies for People Living with Autoimmune and Inflammatory Diseases

globenewswire.com
BMY

Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026

businesswire.com
TEM BMY

SLE Market Evolution Accelerates as AstraZeneca’s Saphnelo SC Emerges as a Likely Key Challenger to GSK’s Benlysta

globenewswire.com
GSK AZN BIIB BMY ABBV

B-Cell Maturation Antigen (BCMA) Targeted Therapies Market Report 2026 - Worth $18.75 Billion in 2026, the Market is Expected to Reach $44.29 Billion by 2030

globenewswire.com
JNJ AZN BMY NVS GSK AMGN

Francois Schramek Promoted to Partner at Manhattan West

prnewswire.com
AI AMN GM LMT NVDA GOOG MSFT SPCE RKLB GD BA AMD INTC META CRWD PLTR AN DD HON RTX IBM AMZN TSLA XOM CVX UNH BMY PFE MRK JNJ LLY GILD REGN BIIB AMGN AZN NVO SNY TEVA BABA JD NTES BIDU IQ VIPS BZUN HTHT MELI BBD BB ERIC NOK QCOM MU ADSK CRM GOOGL

Multiple Sclerosis Market Competitive Landscape Report 2026: Comprehensive Insights on Over 60 Companies and 75 Drugs by Product Type, Development Stage, Administration Route, and Molecule Type

globenewswire.com
SNY IMUX TLSA BIIB BMY TGTX